olmesartan has been researched along with Atrophy in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 22 (84.62) | 24.3611 |
2020's | 4 (15.38) | 2.80 |
Authors | Studies |
---|---|
Cook, DR | 1 |
Gabb, GM; Moore, K; Shukla, N | 1 |
Ahn, B; Hall, SE; Hinkley, JM; Hyatt, H; Morton, AB; Powers, SK; Smuder, AJ; Sollanek, KJ; Wiggs, MP | 1 |
Barbara, G; Bellacosa, L; Capuani, F; Cogliandro, RF; Cremon, C; Marasco, G; Mauloni, PA; Paone, C; Stanghellini, V; Vasuri, F | 1 |
Cartee, AK; Oxentenko, AS; Reyes Genere, JP | 1 |
Alameldin, M; Ghaith, J; Raslan, IA; Szilagyi, A | 1 |
Abu Daya, H; Arguelles-Grande, C; Bhagat, G; DeGaetani, M; Green, PH; Lebwohl, B; Lewis, SK; Tennyson, CA | 1 |
Lewin, M; Nielsen, JA; Steephen, A | 1 |
David, XR; Haramburu, F; Miremont-Salamé, G; Théophile, H | 1 |
Khan, AS; Peter, S; Wilcox, CM | 1 |
Janssen, J; Mulder, CJ; Nijeboer, P; van Beurden, YH; Verbeek, WH | 1 |
Bibbò, S; Cammarota, G; Gasbarrini, A; Ianiro, G; Montalto, M; Ricci, R | 1 |
Llobell, A; Milisenda, JC; Pellicé, M; Téllez, A | 1 |
Agudo Fernández, S | 1 |
Cano Ruiz, A; Crespo Pérez, L; Téllez Villajos, L | 1 |
Cano Ruiz, A; Crespo Pérez, L; Moreira Vicente, V; Téllez Villajos, L | 1 |
Cardoso, H; Coelho, R; Macedo, G; Santos-Antunes, J | 1 |
Colardelle, P; Ould Sidi Mohamed, M | 2 |
Biagi, F; Corazza, GR; Cumetti, D; Luinetti, O; Mugellini, A; Schiepatti, A; Sonzogni, A | 1 |
Gonzalo, DH; Martelli, MG; Naik, DK; Pannu, D; Sharma, AK | 1 |
Capone, P; Caporaso, N; Imperatore, N; Rispo, A; Tortora, R | 1 |
Arnason, T; Igoe, J; Kulai, T; MacIntosh, D | 1 |
Machado, I; Maia de Alcántara, F; Martínez de Juan, F; Martínez Lapiedra, C; Reolid, M | 1 |
Herman, ML; Kelly, DG; Ludvigsson, JF; Mangan, TF; Murray, JA; Rubio-Tapia, A; Wu, TT | 1 |
4 review(s) available for olmesartan and Atrophy
Article | Year |
---|---|
An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy.
Topics: Aged; Atrophy; Celiac Disease; Diarrhea; Humans; Imidazoles; Intestinal Diseases; Male; Tetrazoles; Weight Loss | 2021 |
Systematic review: Sprue-like enteropathy associated with olmesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Duodenum; Humans; Imidazoles; Microvilli; Tetrazoles; Weight Loss | 2014 |
[Non celiac villous atrophy: more confusion or a new syndrome?].
Topics: Atrophy; Autoantibodies; Celiac Disease; Chronic Disease; Collagenous Sprue; Common Variable Immunodeficiency; Diagnosis, Differential; Diarrhea; Duodenum; Enteritis; Enterocytes; Eosinophilia; Gastritis; Humans; Imidazoles; Intestinal Mucosa; Malabsorption Syndromes; Microvilli; Polyendocrinopathies, Autoimmune; Tetrazoles | 2015 |
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
Topics: Aged; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Vomiting; Weight Loss | 2016 |
22 other study(ies) available for olmesartan and Atrophy
Article | Year |
---|---|
Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.
Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Hypertension; Imidazoles; Middle Aged; Tetrazoles | 2020 |
Olmesartan-associated duodenal villous atrophy, an emerging clinical issue.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2020 |
Comparative Efficacy of Angiotensin II Type 1 Receptor Blockers Against Ventilator-Induced Diaphragm Dysfunction in Rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrophy; Diaphragm; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Imidazoles; Irbesartan; Rats; Respiration, Artificial; Tetrazoles; Ventilators, Mechanical | 2021 |
New Onset Villous Atrophy in a Patient With Celiac Disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Celiac Disease; Collagenous Sprue; Diet, Gluten-Free; Female; Humans; Hypertension; Imidazoles; Intestine, Small; Medication Therapy Management; Microvilli; Risk Factors; Tetrazoles | 2018 |
Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology.
Topics: Antibodies; Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Female; Humans; Imidazoles; Intestine, Small; Middle Aged; Tetrazoles; Transglutaminases | 2018 |
Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Atrophy; Autoantibodies; Biopsy; Celiac Disease; Databases, Factual; Duodenum; Female; HLA-DQ Antigens; Humans; Imidazoles; Immunoglobulins; Immunosuppressive Agents; Intestinal Mucosa; Male; Middle Aged; Retrospective Studies; Tetrazoles | 2013 |
Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Duodenoscopy; Duodenum; Female; Humans; Imidazoles; Middle Aged; Regeneration; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Five cases of sprue-like enteropathy in patients treated by olmesartan.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Atrophy; Colitis; Dehydration; Diarrhea; Duodenum; Endoscopy, Gastrointestinal; Female; Humans; Ileitis; Imidazoles; Male; Tetrazoles; Weight Loss | 2014 |
Olmesartan-induced enteropathy resembling celiac disease.
Topics: Aged; Antihypertensive Agents; Atrophy; Capsule Endoscopy; Celiac Disease; Diagnostic Errors; Duodenal Diseases; Female; Humans; Ileitis; Imidazoles; Intestinal Mucosa; Jejunal Diseases; Tetrazoles | 2014 |
[Diarrhoea and malabsorption due to olmesartan use].
Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Humans; Hypertension; Imidazoles; Male; Middle Aged; Netherlands; Olmesartan Medoxomil; Tetrazoles | 2014 |
Olmesartan: sprue-like enteropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Chronic Disease; Diarrhea; Humans; Imidazoles; Intestines; Malabsorption Syndromes; Risk Factors; Tetrazoles; Weight Loss | 2014 |
[Enteropathy associated with chronic use of olmesartan].
Topics: Adenocarcinoma; Aged; Antihypertensive Agents; Atrophy; Celiac Disease; Chronic Disease; Diagnosis, Differential; Diagnostic Errors; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Intestinal Mucosa; Malabsorption Syndromes; Male; Microvilli; Prostatectomy; Prostatic Neoplasms; Tetrazoles | 2015 |
[Sprue-like enteropathy due to olmesartan: a case report].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrophy; Celiac Disease; Chronic Disease; Diarrhea; Female; Humans; Hypertension; Imidazoles; Intestinal Mucosa; Microvilli; Tetrazoles | 2015 |
[Enteropathy by olmesartan].
Topics: Aged; Antihypertensive Agents; Atrophy; Celiac Disease; Chronic Disease; Diagnosis, Differential; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Immunophenotyping; Intestinal Mucosa; Lymphocyte Subsets; Malabsorption Syndromes; Male; Microvilli; Tetrazoles | 2015 |
Drug-induced small-bowel mucosal atrophy.
Topics: Aged; Antihypertensive Agents; Atrophy; Capsule Endoscopy; Chronic Disease; Diarrhea; Duodenum; Humans; Imidazoles; Intestinal Mucosa; Jejunum; Male; Tetrazoles | 2015 |
[Enteropathy due to olmesartan].
Topics: Antihypertensive Agents; Atrophy; Biopsy; Diarrhea; Duodenitis; Duodenum; Essential Hypertension; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Withholding Treatment | 2016 |
Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases.
Topics: Aged; Antihypertensive Agents; Atrophy; Duodenal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles | 2016 |
An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
Topics: Aged, 80 and over; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Imidazoles; Intestinal Diseases; Intestines; Olmesartan Medoxomil; Tetrazoles | 2015 |
An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Duodenal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles | 2016 |
[Enteropathy due to olmesartan].
Topics: Angiotensin II Type 1 Receptor Blockers; Atrophy; Duodenum; Humans; Imidazoles; Intestinal Mucosa; Lymphocytes; Male; Middle Aged; Tetrazoles | 2016 |
Sprue-like enteropathy associated with olmesartan in a patient with villous atrophy, HLA-DQ2 genotype and antinuclear antibodies.
Topics: Aged; Antibodies, Antinuclear; Anticholesteremic Agents; Atrophy; Celiac Disease; Gastrointestinal Diseases; Genotype; HLA-DQ Antigens; Humans; Imidazoles; Male; Tetrazoles | 2016 |
Severe spruelike enteropathy associated with olmesartan.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Anemia; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Colitis, Microscopic; Collagen; Diarrhea; Fatigue; Female; Gastritis; Hospitalization; Humans; Hypoalbuminemia; Imidazoles; Inflammation; Intestinal Mucosa; Intestines; Lymphocytes; Male; Middle Aged; Nausea; Severity of Illness Index; Stomach; Tetrazoles; Vomiting; Water-Electrolyte Imbalance; Weight Loss; Zinc | 2012 |